list price
The high published price of a drug before any rebates, on which patient out-of-pocket and co-insurance costs are often based.
As defined in Robin Feldman on Drugs, Money, and Secret Handshakes
Where it comes up · 7
- Robin Feldman on Drugs, Money, and Secret Handshakes4 claims
- GE: Lessons From the Rise and Fall2 claims
- Embraer: Defying Gravity1 claim
- GE Aerospace: Full Throttle1 claim
- Why Venture is Hard1 claim
- Boeing: Turbulent Times1 claim
- Investing in Healthcare1 claim
Most important claims · 10 of 11Search all claims for “list price” →
- Jetliner list prices are a 'great work of fiction,' with airlines typically getting about 50 percent off, whereas business jet list prices are relatively normal and are inflated mainly by options.Embraer: Defying Gravity
- GE sells aviation engines at a loss to make it up in highly profitable parts and service revenue that provides multi-decade benefits, which is the key reason aviation deserves a wide moat; customers routinely pay 70% below list price, and discounts hover over 50% off list.GE: Lessons From the Rise and Fall
- On average across the United States, students pay about 50 percent of college list price according to the Department of Education, and most colleges outside the top 1 percent struggle to fill seats, so they will negotiate merit scholarships for desirable students at a cost far below what they spend on student acquisition.Why Venture is Hard
- Drug prices involve multiple layers across the supply chain: the pharmacy buys at a wholesale price, bills the insurer at list price, and the insurer receives a manufacturer rebate, so the net price the insurer actually pays can be far below list, and net prices have not risen as sharply as list prices.Investing in Healthcare
- LEAP's list price of roughly $20–22 million is about 20% of the aircraft price, but OE pricing can be discounted by 70–80% until the program matures, with GE's realized revenue per engine around $6 million.GE Aerospace: Full Throttle
- Drug companies raise list prices each year before granting a rebate to PBMs, so the PBM can claim to have negotiated a great deal—analogous to a department store raising prices right before a sale—while patients on high-deductible or co-insurance plans actually pay based on the inflated list price.Robin Feldman on Drugs, Money, and Secret Handshakes
- The LEAP engine lists at about $14 million, but airlines and airframers routinely pay around 70% below list, with discounts that analysts estimate still hover over 50% off list.GE: Lessons From the Rise and Fall
- Single-aisle aircraft list at $110 million to $130 million, but discounts of 40% to 60% are typical, so airlines pay roughly $50 million to $55 million, while all-in build cost for mature programs like the A320 or 737 is roughly $25 million to $35 million.Boeing: Turbulent Times
- Because commercial-plan rebates are reported at only 20-30% off a list price that has itself risen ~60% over four years, the post-rebate price still rises year over year and becomes a floor rather than a ceiling, against which new drugs can launch even higher and look cheap, and generics can drop just slightly and claim to be a bargain.Robin Feldman on Drugs, Money, and Secret Handshakes
- Under the ACA, once a Medicare patient reaches the out-of-pocket threshold the government pays 80% of the cost (reinsurance), so a plan that prefers an expensive brand over a generic actually saves money because the super-high brand price pushes the patient through the donut hole faster onto the taxpayer-funded reinsurance—good for the plan, great for the drug company, bad for taxpayers, while the patient's cost-sharing is still based on the high list price.Robin Feldman on Drugs, Money, and Secret Handshakes